Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Argeron logo — Discover healthfully

Argeron

Discover healthfully

Founded 2012 Turkey Turkey 2-10 employees

General Information

Company Name Argeron
Founded Year 2012
Location Turkey Turkey +2
Employees 2-10
Social

Get notified when Argeron moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Argeron

Argeron is a global leader in the research, development, and production of innovative diagnostic kits focused on the early detection of diseases associated with aging, such as cancer, kidney failure, Alzheimer's, and dementia. The company's products are manufactured within IVDR quality standards and have obtained ÜTS and CE quality certifications. Additionally, Argeron is in the process of securing both national and international patents for their advanced technologies. Founded by Prof. Dr. Abdullah OLGUN in 2012 at the Antalya Technopark, Argeron initially began as the first Biogerontology Laboratory, concentrating on the biology of aging and the development of compounds effective on aging. The company has since expanded its focus to include the creation of new medical products, with their first innovative product being the TİT-UriCollecT®, a standardized tube-based urine collection system for microscopic analysis. Argeron has achieved notable recognition within the industry, earning first prize in the Health Category at the 11th TET Project Market and being acknowledged as a Deep Technology Pioneer in the Health sector by Hello Tomorrow. Furthermore, the company was one of the two startups selected for the Bayer G4A Turkey 2022 Health Category. As of now, there is no specific information available regarding the last investment received by Argeron or the involved investors. The company is headquartered in Turkey and continues to make strides in the healthcare sector with its innovative and impactful diagnostic solutions.

Taxonomy: biogerontology, biology of aging, medical products, biogerontology laboratory, aging research, biomedical research, anti-aging solutions, longevity, medical innovation

No funding data available for Argeron yet.

Get notified when Argeron raises funding

Argeron Alternatives & Competitors

Argeron vs
Calico Life Sciences
Calico Life Sciences United States

We're tackling aging, one of life's greatest mysteries

Seed
479 employees
Biotechnology, Health Care
Argeron vs
Regenstrief Institute, Inc.
Regenstrief Institute, Inc. United States

Research to transform health systems and communities for a healthier, more equitable world.

277 employees
Health Care
Argeron vs
Cible Skin
Cible Skin France

Reversing skin aging through immune resilience. 1-LGVTY®: Cible Skin’s patented longevity technology...

Unknown
38 employees

FAQ About Argeron

Discover healthfully
Argeron was founded in 2012.
Argeron is headquartered in Turkey.
Argeron has approximately 2-10 employees.
Top alternatives and competitors to Argeron include Calico Life Sciences, Regenstrief Institute, Inc., Cible Skin, Cogniciti, Singular Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Argeron and Calico Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Argeron and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy